In the previous study, Bexarotene increases the removal of soluble Aβ by microglia in an ApoE-dependent manner, and sodium rutin ameliorates AD-like pathology by enhancing microglial Aβ clearance [19, 23]. Here, APOE is linked to Alzheimer disease.